ng-nitroarginine methyl ester has been researched along with Lesch-Nyhan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belluardo, N; Caciagli, F; Ciccarelli, R; Condorelli, DF; Di Iorio, P; Frinchi, M; Jinnah, HA; Mudò, G; Mulè, F; Nuzzo, D; Serio, R; Zizzo, MG | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Lesch-Nyhan Syndrome
Article | Year |
---|---|
Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.
Topics: Animals; Atropine; Benzazepines; Brain; Carbachol; Cytokines; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Evoked Potentials; Face; Gastrointestinal Motility; Gene Expression Regulation; Hypoxanthine Phosphoribosyltransferase; In Vitro Techniques; Lesch-Nyhan Syndrome; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth; Neurotransmitter Agents; NG-Nitroarginine Methyl Ester; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2018 |